US Stock MarketDetailed Quotes

OPRX OptimizeRx

Watchlist
  • 4.805
  • -0.055-1.13%
Close Jan 17 16:00 ET
  • 4.805
  • 0.0000.00%
Post 16:02 ET
88.51MMarket Cap-3.59P/E (TTM)

OptimizeRx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

OptimizeRx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 21.260M--
--2024/Q4-- / 30.642M--
Nov 13, 20242024/Q321.309M / 24.997M--
Aug 8, 20242024/Q218.812M / 20.463M--
May 14, 20242024/Q119.690M / 18.132M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 21.260M--
--2024/Q4-- / 30.642M--
Nov 13, 20242024/Q321.309M / 24.997M--
Aug 8, 20242024/Q218.812M / 20.463M--
May 14, 20242024/Q119.690M / 18.132M--

Unlock Free Earnings Estimates

OptimizeRx Earnings Reports

  • OptimizeRx | 10-Q: Q3 2024 Earnings Report

    Nov 14, 2024 15:37 ET

  • OptimizeRx | 8-K: OptimizeRx Reports Third Quarter 2024 Financial Results

    Nov 13, 2024 16:17 ET

  • OptimizeRx | 10-Q: Q2 2024 Earnings Report

    Aug 15, 2024 16:34 ET

  • OptimizeRx | 8-K: OptimizeRx Reports Second Quarter 2024 Financial Results

    Aug 8, 2024 16:31 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 17, 2025

    Buy

    • Buy

      57.14%

    • Hold

      42.86%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data